Detection and characterization of carcinoma cells in the blood

E. Racila, David M Euhus, A. J. Weiss, C. Rao, J. McConnell, L. W M M Terstappen, J. W. Uhr

Research output: Contribution to journalArticle

Abstract

A highly sensitive assay combining immunomagnetic enrichment with multiparameter flow cytometric and immunocytochemical analysis has been developed to detect, enumerate, and characterize carcinoma cells in the blood. The assay can detect one epithelial cell or less in 1 ml of blood. Peripheral blood (10-20 ml) from 30 patients with carcinoma of the breast, from 3 patients with prostate cancer, and from 13 controls was examined by flow cytometry for the presence of circulating epithelial cells defined as nucleic acid+, CD45-, and cytokeratin+. Highly significant differences in the number of circulating epithelial cells were found between normal controls and patients with cancer including 17 with organ-confined disease. To determine whether the circulating epithelial cells in the cancer patients were neoplastic cells, cytospin preparations were made after immunomagnetic enrichment and were analyzed. Epithelial cells from patients with breast cancer generally stained with mAbs against cytokeratin and 3 of 5 for mucin- 1. In contrast, no cells that stained for these antigens were observed in the blood from normal controls. The morphology of the stained cells WaS consistent with that of neoplastic cells. Of 8 patients with breast cancer followed for 1-10 months, there was a good correlation between changes in the level of tumor cells in the blood with both treatment with chemotherapy and clinical status. The present assay may be helpful in early detection, in monitoring disease, and in prognostication.

Original languageEnglish (US)
Pages (from-to)4589-4594
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume95
Issue number8
DOIs
StatePublished - Apr 14 1998
Externally publishedYes

Fingerprint

Blood Cells
Carcinoma
Epithelial Cells
Breast Neoplasms
Keratin-3
Keratin-5
Mucin-1
Neoplasms
Keratins
Nucleic Acids
Prostatic Neoplasms
Flow Cytometry
Antigens
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Detection and characterization of carcinoma cells in the blood. / Racila, E.; Euhus, David M; Weiss, A. J.; Rao, C.; McConnell, J.; Terstappen, L. W M M; Uhr, J. W.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 95, No. 8, 14.04.1998, p. 4589-4594.

Research output: Contribution to journalArticle

Racila, E. ; Euhus, David M ; Weiss, A. J. ; Rao, C. ; McConnell, J. ; Terstappen, L. W M M ; Uhr, J. W. / Detection and characterization of carcinoma cells in the blood. In: Proceedings of the National Academy of Sciences of the United States of America. 1998 ; Vol. 95, No. 8. pp. 4589-4594.
@article{cadbf5b628ac4053a026255ddd2290e2,
title = "Detection and characterization of carcinoma cells in the blood",
abstract = "A highly sensitive assay combining immunomagnetic enrichment with multiparameter flow cytometric and immunocytochemical analysis has been developed to detect, enumerate, and characterize carcinoma cells in the blood. The assay can detect one epithelial cell or less in 1 ml of blood. Peripheral blood (10-20 ml) from 30 patients with carcinoma of the breast, from 3 patients with prostate cancer, and from 13 controls was examined by flow cytometry for the presence of circulating epithelial cells defined as nucleic acid+, CD45-, and cytokeratin+. Highly significant differences in the number of circulating epithelial cells were found between normal controls and patients with cancer including 17 with organ-confined disease. To determine whether the circulating epithelial cells in the cancer patients were neoplastic cells, cytospin preparations were made after immunomagnetic enrichment and were analyzed. Epithelial cells from patients with breast cancer generally stained with mAbs against cytokeratin and 3 of 5 for mucin- 1. In contrast, no cells that stained for these antigens were observed in the blood from normal controls. The morphology of the stained cells WaS consistent with that of neoplastic cells. Of 8 patients with breast cancer followed for 1-10 months, there was a good correlation between changes in the level of tumor cells in the blood with both treatment with chemotherapy and clinical status. The present assay may be helpful in early detection, in monitoring disease, and in prognostication.",
author = "E. Racila and Euhus, {David M} and Weiss, {A. J.} and C. Rao and J. McConnell and Terstappen, {L. W M M} and Uhr, {J. W.}",
year = "1998",
month = "4",
day = "14",
doi = "10.1073/pnas.95.8.4589",
language = "English (US)",
volume = "95",
pages = "4589--4594",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "8",

}

TY - JOUR

T1 - Detection and characterization of carcinoma cells in the blood

AU - Racila, E.

AU - Euhus, David M

AU - Weiss, A. J.

AU - Rao, C.

AU - McConnell, J.

AU - Terstappen, L. W M M

AU - Uhr, J. W.

PY - 1998/4/14

Y1 - 1998/4/14

N2 - A highly sensitive assay combining immunomagnetic enrichment with multiparameter flow cytometric and immunocytochemical analysis has been developed to detect, enumerate, and characterize carcinoma cells in the blood. The assay can detect one epithelial cell or less in 1 ml of blood. Peripheral blood (10-20 ml) from 30 patients with carcinoma of the breast, from 3 patients with prostate cancer, and from 13 controls was examined by flow cytometry for the presence of circulating epithelial cells defined as nucleic acid+, CD45-, and cytokeratin+. Highly significant differences in the number of circulating epithelial cells were found between normal controls and patients with cancer including 17 with organ-confined disease. To determine whether the circulating epithelial cells in the cancer patients were neoplastic cells, cytospin preparations were made after immunomagnetic enrichment and were analyzed. Epithelial cells from patients with breast cancer generally stained with mAbs against cytokeratin and 3 of 5 for mucin- 1. In contrast, no cells that stained for these antigens were observed in the blood from normal controls. The morphology of the stained cells WaS consistent with that of neoplastic cells. Of 8 patients with breast cancer followed for 1-10 months, there was a good correlation between changes in the level of tumor cells in the blood with both treatment with chemotherapy and clinical status. The present assay may be helpful in early detection, in monitoring disease, and in prognostication.

AB - A highly sensitive assay combining immunomagnetic enrichment with multiparameter flow cytometric and immunocytochemical analysis has been developed to detect, enumerate, and characterize carcinoma cells in the blood. The assay can detect one epithelial cell or less in 1 ml of blood. Peripheral blood (10-20 ml) from 30 patients with carcinoma of the breast, from 3 patients with prostate cancer, and from 13 controls was examined by flow cytometry for the presence of circulating epithelial cells defined as nucleic acid+, CD45-, and cytokeratin+. Highly significant differences in the number of circulating epithelial cells were found between normal controls and patients with cancer including 17 with organ-confined disease. To determine whether the circulating epithelial cells in the cancer patients were neoplastic cells, cytospin preparations were made after immunomagnetic enrichment and were analyzed. Epithelial cells from patients with breast cancer generally stained with mAbs against cytokeratin and 3 of 5 for mucin- 1. In contrast, no cells that stained for these antigens were observed in the blood from normal controls. The morphology of the stained cells WaS consistent with that of neoplastic cells. Of 8 patients with breast cancer followed for 1-10 months, there was a good correlation between changes in the level of tumor cells in the blood with both treatment with chemotherapy and clinical status. The present assay may be helpful in early detection, in monitoring disease, and in prognostication.

UR - http://www.scopus.com/inward/record.url?scp=0032516046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032516046&partnerID=8YFLogxK

U2 - 10.1073/pnas.95.8.4589

DO - 10.1073/pnas.95.8.4589

M3 - Article

C2 - 9539782

AN - SCOPUS:0032516046

VL - 95

SP - 4589

EP - 4594

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 8

ER -